drugset / Trial / NCT06454825

Effects of Antiemetic Agents in Orthognathic Surgery Patients

NCT06454825

Phase 4 Completed 66 enrolled Bezmialem Vakif University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

In an effort to prevent or treat consistently high rates of PONV following maxillofacial operations, several medications, techniques and multimodal protocols have been studied. In the present study, the investigators hypothesized that combining metoclopramide with granisetron will improve PONV incidence when compared with granisetrone alone.

Timeline

Start
2020-04-14
Primary completion
2021-04-05
Completion
2021-04-05

Drugs

EvaluationDrugModalityDoseRoute
Subject AUY922 Small molecule 10 mg Intravenous
Subject Granisetron Other / unclassified 3 mg Intravenous